← All trials
NCT05944224
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 17, 2023
- Primary completion
- May 31, 2025
- Completion date
- Dec 31, 2025
- First posted
- Jul 13, 2023
- Last posted
- Oct 19, 2023
- Enrollment
- 63
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Shanghai Pharmaceuticals Holding Co., LtdLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.